Works matching IS 10538569 AND DT 2023 AND VI 32
Results: 175
Correction to "Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain".
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1446, doi. 10.1002/pds.5712
- Publication type:
- Article
A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1319, doi. 10.1002/pds.5691
- By:
- Publication type:
- Article
Identification of risk factors for adverse drug reactions in a pharmacovigilance database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1431, doi. 10.1002/pds.5679
- By:
- Publication type:
- Article
Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1406, doi. 10.1002/pds.5676
- By:
- Publication type:
- Article
Validation of ICD‐10 hospital discharge diagnosis codes to identify incident and recurrent ischemic stroke from a US integrated healthcare system.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1439, doi. 10.1002/pds.5675
- By:
- Publication type:
- Article
Importance of accounting for timing of time‐varying exposures in association studies: Hydrochlorothiazide and non‐melanoma skin cancer.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1411, doi. 10.1002/pds.5674
- By:
- Publication type:
- Article
Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1395, doi. 10.1002/pds.5672
- By:
- Publication type:
- Article
Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1350, doi. 10.1002/pds.5665
- By:
- Publication type:
- Article
Risk of cancer with immunosuppressants compared to immunomodulators in multiple sclerosis: A nested case–control study within the French nationwide claims database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1421, doi. 10.1002/pds.5669
- By:
- Publication type:
- Article
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1378, doi. 10.1002/pds.5668
- By:
- Publication type:
- Article
Sex‐specific incidence of hepatitis B virus flares among Bcr‐Abl tyrosine kinase inhibitor users in Taiwan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1368, doi. 10.1002/pds.5667
- By:
- Publication type:
- Article
External validity in distributed data networks.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1360, doi. 10.1002/pds.5666
- By:
- Publication type:
- Article
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post‐marketing surveillance.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1387, doi. 10.1002/pds.5671
- By:
- Publication type:
- Article
Decision and timing of safety‐related labeling changes for new drugs in Japan: Comparison with the United States and the European Union.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1331, doi. 10.1002/pds.5664
- By:
- Publication type:
- Article
Investigation of hepatic adverse events due to quetiapine by using the common data model.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1341, doi. 10.1002/pds.5663
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1448, doi. 10.1002/pds.5476
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 12, p. 1, doi. 10.1002/pds.5475
- Publication type:
- Article
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1189, doi. 10.1002/pds.5677
- By:
- Publication type:
- Article
Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1306, doi. 10.1002/pds.5670
- By:
- Publication type:
- Article
Validation of an algorithm to identify fractures among patients within the Veterans Health Administration.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1290, doi. 10.1002/pds.5662
- By:
- Publication type:
- Article
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1271, doi. 10.1002/pds.5660
- By:
- Publication type:
- Article
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1280, doi. 10.1002/pds.5659
- By:
- Publication type:
- Article
Identifying inpatient mortality in MarketScan claims data using machine learning.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1299, doi. 10.1002/pds.5658
- By:
- Publication type:
- Article
Barbro Westerholm, 1933–2023.
- Published in:
- 2023
- By:
- Publication type:
- Obituary
Prevalent new user designs: A literature review of current implementation practice.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1252, doi. 10.1002/pds.5656
- By:
- Publication type:
- Article
An algorithm‐based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1261, doi. 10.1002/pds.5655
- By:
- Publication type:
- Article
Impact of hemoglobin A1c level on the association between non‐steroidal anti‐inflammatory drug use and cardiovascular events in patients with type 2 diabetes: A population‐based cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1233, doi. 10.1002/pds.5652
- By:
- Publication type:
- Article
Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1223, doi. 10.1002/pds.5650
- By:
- Publication type:
- Article
Purine antimetabolites associated Pneumocystis jirovecii pneumonia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1244, doi. 10.1002/pds.5647
- By:
- Publication type:
- Article
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1315, doi. 10.1002/pds.5646
- By:
- Publication type:
- Article
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research<sup>+</sup>.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1200, doi. 10.1002/pds.5640
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1318, doi. 10.1002/pds.5474
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 11, p. 1, doi. 10.1002/pds.5473
- Publication type:
- Article
Author Index.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, p. 643, doi. 10.1002/pds.5689
- Publication type:
- Article
STUDENT ABSTRACTS of ISPE's 2023 Mid‐Year Meeting, Reykjavik, Iceland, 23–25 April 2023.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, p. 613, doi. 10.1002/pds.5688
- Publication type:
- Article
Abstracts of ICPE 2023, the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Canada, 25–27 August 2023.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, p. 3, doi. 10.1002/pds.5687
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, p. 1, doi. 10.1002/pds.5686
- Publication type:
- Article
Switching patterns of immediate‐release forms of generic mixed amphetamine salts products among privately and publicly insured individuals aged 15–64 years in the United States, 2013–2019.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1178, doi. 10.1002/pds.5661
- By:
- Publication type:
- Article
Trajectories of ADHD medication use before, during, and after pregnancy: A population‐based study from Norway and Sweden.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1152, doi. 10.1002/pds.5654
- By:
- Publication type:
- Article
Selective serotonin reuptake inhibitors, post‐treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1053, doi. 10.1002/pds.5653
- By:
- Publication type:
- Article
Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1142, doi. 10.1002/pds.5651
- By:
- Publication type:
- Article
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1121, doi. 10.1002/pds.5648
- By:
- Publication type:
- Article
To wait or not to wait: Weighing the pros and cons of early identification of safety concerns for medications used in pregnancy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1184, doi. 10.1002/pds.5645
- By:
- Publication type:
- Article
A feasibility assessment of real‐world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1131, doi. 10.1002/pds.5644
- By:
- Publication type:
- Article
The utility of the self‐controlled study design for pharmacoepidemiological studies without an active comparator medication using a medical information database: An application to assess the risk of varenicline on cardiovascular outcomes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1068, doi. 10.1002/pds.5634
- By:
- Publication type:
- Article
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1083, doi. 10.1002/pds.5641
- By:
- Publication type:
- Article
Differences in target estimands between different propensity score‐based weights.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1103, doi. 10.1002/pds.5639
- By:
- Publication type:
- Article
Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1077, doi. 10.1002/pds.5638
- By:
- Publication type:
- Article
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1161, doi. 10.1002/pds.5637
- By:
- Publication type:
- Article
The most common medications dispensed to lactating persons: An electronic health record‐based approach.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 10, p. 1113, doi. 10.1002/pds.5643
- By:
- Publication type:
- Article